At the Bedside
- Immediate assessment
- ABCs first: assess respiratory rate, oxygen saturation, ETCO₂ if available, mental status, airway protection.
- Classic toxidrome: CNS depression + respiratory depression + miosis. Miosis may be absent with hypoxia, co-ingestions, meperidine, tramadol, or severe poisoning.
- Look for trauma, aspiration, pulmonary edema, hypoglycemia, needle marks, fentanyl patches, clonidine co-ingestion.
- Initial ED actions
- High-flow O₂; assist ventilation with BVM if bradypneic/apneic.
- Place patient on cardiac monitor, pulse ox, and ideally capnography.
- Check POC glucose early in all altered patients.
- IV access; consider IO if unstable and IV delayed.
- Naloxone strategy
- Goal: restore adequate ventilation, not necessarily normal mentation.
- In opioid-dependent patients, start low and titrate to avoid severe withdrawal, agitation, vomiting, aspiration.
- In apnea or near-arrest, give larger doses immediately.
- Re-dose as needed; fentanyl analogs, methadone, extended-release opioids, and body stuffing/packing may require repeated doses or infusion.
- Diagnostic workup
- Often clinical diagnosis.
- POC glucose.
- ECG if methadone, loperamide, co-ingestion, syncope, or unknown overdose.
- Acetaminophen/salicylate levels and ethanol level are reasonable in intentional/unknown ingestions.
- VBG/ABG if severe hypoventilation, persistent AMS, or respiratory failure.
- CXR if hypoxia, aspiration concern, pulmonary edema.
- Urine drug screen has limited ED utility; fentanyl often not detected on standard screens.
- Complications
- Aspiration pneumonitis/pneumonia.
- Noncardiogenic pulmonary edema after overdose or naloxone.
- Rhabdomyolysis from prolonged down time.
- Withdrawal after naloxone: agitation, vomiting, diarrhea, tachycardia, hypertension.
- Disposition
- Observe until awake, breathing normally, and no recurrent sedation after naloxone.
- Short-acting opioid reversed with naloxone: often observe 2–4 hours after last naloxone if clinically stable.
- Admit/extended observation if long-acting opioid, methadone, buprenorphine, recurrent naloxone needs, naloxone infusion, hypoxia, aspiration, pulmonary edema, significant co-ingestion, suicidal intent, pregnancy, unreliable follow-up.
- Offer harm reduction: take-home naloxone, fentanyl test strips where available, buprenorphine initiation if opioid use disorder and appropriate.
Study Directive
- Practice a 60-second opioid overdose script: airway, glucose, BVM, naloxone titration, reassessment.
- Memorize naloxone titration: 0.04 mg IV for dependent/non-apneic patients; 0.4–2 mg for apnea/severe depression; infusion = 2/3 wake-up dose per hour.
- Review criteria for safe discharge after naloxone and list 5 reasons for admission.
- Simulate counseling: prescribe take-home naloxone and offer buprenorphine initiation for OUD.
Recent Literature
- Review or guideline 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
- Recent clinical Levamisole in opioid overdose patients: An evolving adulterant landscape